Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer

Completed · Phase 1 · Has a placebo group

Conditions studied: Anemia

In brief

This pilot study is looking at how well epoetin alfa, given in the immediate post-operative period, works in reducing anemia and the need for transfusions.

Key facts

Study ID

NCT00294203

Run by

University of Florida

People needed

40

Starts

2006-02-01

Expected to finish

2008-12-01

Last updated by the study team

2014-04-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing esophagectomy, gastrectomy, partial pancreatectomy, hepatic resection, or low anterior resection of rectum for malignancy
• Patients with hemoglobin greater than 8 and less than 11 g/dL on post-operative day #1.

You may not qualify if…

• Patients receiving red blood cell transfusion within the first twelve hours post-operatively.
• Patients receiving epoetin-stimulating proteins within 30 days prior to the operation.

Where it is running

• Shands Hospital at the University of Florida — Gainesville, Florida, United States
• University of Florida Shands Cancer Center — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.